NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 10:14 AM
NASDAQ TRADE HALT FRBN.O VOLATILITY TRADING PAUSE AT 10:14 AM
Recent news on enGene Therapeutics
See all newsenGene Therapeutics Inc. reports results for the quarter ended July 31 - Earnings Summary
enGene Therapeutics Inc. expected to post a loss of 43 cents a share - Earnings Preview
Brief: Engene Reports Second Quarter 2026 Financial Results And Provides Business Update
enGene Therapeutics Inc expected to post a loss of 47 cents a share - Earnings Preview
Brief: Engene Holdings Inc - To Change Name To Engene Therapeutics Inc. Effective April 8, 2026